Mireia Morgades

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 253 citations · Full text

Medicine, Hematology, Oncology +17

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Nicola Gökbuget, Hervé Dombret, Josep‐María Ribera et al. · Haematologica · 2016 · 222 citations · Full text

Medicine, Hematology, Oncology +14

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

Nicola Gökbuget, Michael A. Kelsh, Victoria Chia et al. · Blood Cancer Journal · 2016 · 128 citations · Full text

Medicine, Hematology, Oncology +16

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma

Blanca Xicoy, Josep‐María Ribera, Pilar Miralles et al. · Haematologica · 2007 · 123 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus‐associated diffuse large B‐cell lymphoma: results of a phase II trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · British Journal of Haematology · 2007 · 111 citations

Medicine, Oncology, Pharmacology +15